Atlas Trials

Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

Clinical trial NCT04152356 · UNKNOWN

Trial details

NCT number
NCT04152356
Sponsor
Guangxi Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
HepatoCellular Carcinoma
Start date
2019-11-01
Primary completion
2020-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.